On December 18, 2023, Structure Therapeutics published the latest clinical data for GSBR-1290 on its official website.175 Currently, GSBR-1290 is undergoing a 12-week Phase 2a randomized, double-blind, placebo-controlled clinical trial to assess its effectiveness in treating patients with T2DM and obesity
No independent research group has conducted a properly powered, double-blind, placebo-controlled trial of topical GHK-Cu for skin aging
Each capsule has 100mg of L-Glutathione, 200mg Vitamic C, 40mg Grapeseed Extract, 100mg N-Acetyl-L-Cysteine, 100mg Hydrolyzed Bovine Collagen, 200mg Placenta Powder, 100mg Ste-Cell (fruits), 50mg Lycopene and 10mg Fucus Vesiculosus, which is 90% Fucoidan
Chronic oxidative stress, mitochondrial dysfunction, Nrf2 activation and inflammation in the hippocampus accompany heightened systemic inflammation and oxidative stress in an animal model of Gulf War illness
L-carnitine is particularly beneficial for those seeking long-term weight management, as it encourages the body to rely more on fat as an energy source rather than muscle glycogen
Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism